Valuation: Kenvue Inc.

Market Cap 37.32B 31.98B 29.92B 27.36B 51.62B 3,574B 52.17B 354B 138B 1,794B 140B 137B 5,937B P/E 2026 *
20.4x
P/E 2027 * 17.7x
Enterprise Value 44.42B 38.07B 35.61B 32.56B 61.44B 4,253B 62.09B 421B 164B 2,136B 167B 163B 7,066B EV / Sales 2026 *
2.85x
EV / Sales 2027 * 2.75x
Free-Float
98.88%
Yield 2026 *
4.34%
Yield 2027 * 4.43%
1 day+1.94%
1 week+3.41%
Current month+0.99%
1 month+0.78%
3 months+10.84%
6 months+2.21%
Current year+12.64%
1 week 18.87
Extreme 18.87
19.56
1 month 18.65
Extreme 18.65
20.05
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
21.4
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap.
7/31/26 Fiscal year

Executive/Senior Manager

32,838 0.0017%
5/1/26 Fiscal year

Group President LATAM

55,637 0.0029%
3/30/26 Free

Director

1,331 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+1.94%+3.41%-10.09%-17.88% 37.32B
+1.33%+2.43%-7.61%-3.89% 341B
+2.17%+5.98%-8.81%+5.78% 140B
+1.61%+2.59%+7.69%+26.23% 73.78B
-0.33%-0.54%-23.09%-21.05% 49.81B
+2.15%+23.46%+14.14%-30.92% 37.67B
+1.32%+3.11%+7.34%+30.92% 20.29B
+2.82%+4.77%+10.14%+10.75% 20.09B
-0.59%-0.82%-26.81%-10.38% 9.93B
-0.98%-2.21%-23.91%-29.29% 7.38B
Average +0.79%+4.16%-6.10%-3.97% 73.75B
Weighted average by Cap. -0.20%+3.98%-5.89%-1.27%

Financials

2026 *2027 *
Net sales 15.6B 13.37B 12.5B 11.43B 21.57B 1,493B 21.8B 148B 57.53B 750B 58.56B 57.29B 2,481B 15.97B 13.68B 12.8B 11.7B 22.08B 1,529B 22.32B 151B 58.9B 768B 59.95B 58.65B 2,540B
Net income 1.83B 1.57B 1.47B 1.34B 2.53B 175B 2.56B 17.36B 6.75B 87.99B 6.87B 6.72B 291B 2.11B 1.81B 1.69B 1.55B 2.92B 202B 2.95B 20.04B 7.79B 102B 7.93B 7.76B 336B
Net Debt 7.1B 6.08B 5.69B 5.2B 9.82B 680B 9.92B 67.33B 26.18B 341B 26.65B 26.07B 1,129B 6.52B 5.59B 5.23B 4.78B 9.02B 624B 9.11B 61.85B 24.05B 313B 24.48B 23.95B 1,037B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-08-24 US$19.43 +1.94% 16,103,010
26-08-21 US$19.06 +0.69% 13,572,635
26-08-20 US$18.93 -1.05% 17,706,411
26-08-19 US$19.13 +1.76% 36,188,250
26-08-18 US$18.80 +0.05% 25,521,737
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
19.43USD
Average target price
19.50USD
Spread / Average Target
+0.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock